Icad Inc (ICAD) Inventory Turnover Ratio, from first quarter 2025 to first quarter 2024, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Icad Inc  (NASDAQ: ICAD)
 

Icad Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Icad Inc's inventory turnover ratio, the ratio that measures Icad Inc's ability to manage its supply chain, sequentially decreased to 3.97 in the first quarter 2025, but it does not raise any concerns as Icad Inc continue to execute well, and the inventory turnover ratio remains above the average. Icad Inc's average inventory processing period in the Mar 31 2025 quarter, has increased to 92 days, from 89 days, in the Dec 31 2024 quarter.

Within Healthcare sector 94 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 807, from total ranking in the fourth quarter 2024 at 1077.

ICAD Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Icad Inc Market Share?

What is Inventory Turnover Ratio?




ICAD Inventory Turnover Ratio (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
I. Quarter
Y / Y Inventory Growth -7.47 % -17.56 % -30.54 % -83.47 % -84.59 %
Y / Y Cost of Sales Growth -18.55 % 76.56 % 5.62 % -18.8 % -48.97 %
Inventory Turnover Ratio (TTM) 3.97 4.11 3.47 3.12 1.63
ICAD's Total Ranking # 807 # 1077 # 638 # 655 # 1081
Average inventory processing period 92 89 105 117 224
Seq. Inventory Growth -8.2 % 9.72 % -1.85 % -6.4 % -18.21 %
Seq. Cost of Sales Growth -7.18 % 26.59 % -28.2 % -3.45 % 101.2 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 36
Healthcare Sector # 95
Overall Market # 807

Inventory Turnover Ratio Statistics
High Average Low
4.11 2.45 1.15
(Dec 31 2024)   (Sep 30 2013)




Financial Statements
Icad Inc's Inventories $ 1 Millions Visit ICAD's Balance sheet
Icad Inc's Cost of Revenues TTM $ 3 Millions Visit ICAD's Income Statement
What are ICAD's Sales? Visit ICAD's Sales by Segment

Other Inventory Turnover Ratios
Icad Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ICAD's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ICAD's Competitors
Inventory Turnover Ratio for ICAD's Suppliers
Inventory Turnover Ratio for ICAD's Customers

You may also want to know
ICAD's Sales Growth Rates ICAD's Pe Price to earnings ratio ICAD's Receivables Turnover Ratio ICAD's Stock Quote
ICAD's Net Income Growth Rates ICAD's Ps Price to Sales ratio ICAD's Sales per Employee ICAD's Asset Turnover Ratio
ICAD's Net Margin ICAD's Pb Price to Book ratio ICAD's Financial Strength Ratios ICAD's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Cryo cell International Inc   10.99 $ 7.772  Millions$ 1  Millions
Lifemd Inc   10.70 $ 28.000  Millions$ 3  Millions
Genedx Holdings Corp   10.27 $ 114.000  Millions$ 11  Millions
Infusystem Holdings Inc  9.86 $ 64.486  Millions$ 7  Millions
Myriad Genetics Inc   9.19 $ 248.400  Millions$ 27  Millions
Sotera Health Company  8.95 $ 496.000  Millions$ 55  Millions
Puma Biotechnology Inc   8.80 $ 64.232  Millions$ 7  Millions
National Vision Holdings Inc   8.57 $ 773.700  Millions$ 90  Millions
Castle Biosciences Inc   8.48 $ 62.694  Millions$ 7  Millions
Opko Health Inc   8.19 $ 492.091  Millions$ 60  Millions
Blue Water Vaccines Inc  8.08 $ 1.013  Millions$ 0  Millions
Collegium Pharmaceutical Inc   8.07 $ 279.661  Millions$ 35  Millions
Lantheus Holdings Inc   7.93 $ 552.000  Millions$ 70  Millions
Nutriband Inc   7.65 $ 1.568  Millions$ 0  Millions
Twist Bioscience Corporation  7.65 $ 185.307  Millions$ 24  Millions
Cardiff Lexington Corporation  7.56 $ 4.081  Millions$ 1  Millions
Inogen Inc   7.44 $ 183.218  Millions$ 25  Millions
Hims and Hers Health Inc   7.11 $ 409.000  Millions$ 58  Millions
Evolus Inc   6.89 $ 86.903  Millions$ 13  Millions
Warby Parker Inc   6.86 $ 355.000  Millions$ 52  Millions
Fonar Corporation  6.81 $ 18.904  Millions$ 3  Millions
Vanda Pharmaceuticals Inc   6.77 $ 11.395  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  6.72 $ 71.008  Millions$ 11  Millions
Kewaunee Scientific Corporation  6.68 $ 171.000  Millions$ 26  Millions
Star Equity Holdings Inc   6.67 $ 44.548  Millions$ 7  Millions
Carlisle Companies Incorporated  6.62 $ 3,128.400  Millions$ 473  Millions
Neuronetics Inc   6.59 $ 32.000  Millions$ 5  Millions
Tarsus Pharmaceuticals Inc   6.32 $ 16.383  Millions$ 3  Millions
Charles River Laboratories International inc   6.18 $ 1,937.574  Millions$ 314  Millions
Earth Science Tech Inc   6.17 $ 2.301  Millions$ 0  Millions

Date modified: 2026-08-29T17:23:56+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.